BrandShield is helping members of the Pharmaceutical Security Institute remove online threats.
BrandShield, a leading provider of cyber solutions from brand protection to online threat hunting, has been awarded a contract with the Pharmaceutical Security Institute (PSI).
Based in Washington DC, PSI was set up in 2002 by the security directors from 14 major pharmaceutical companies. Working with its members, PSI has developed improved systems to identify the extent of the problem of counterfeit medicinal products and to assist in co-ordinating international inquiries.
BrandShield has entered into a contract with PSI on a joint program to focus on helping to detect and remove online threats on behalf of several of PSI’s members, such as rogue pharmacies, counterfeit sales of drugs on online marketplaces and social media phishing campaigns. These members include some involved in developing COVID-19 vaccines.
Yoav Keren, BrandShield CEO, said: “One of the biggest sectors being targeted by online scammers and con artists is pharmaceuticals. Cybercriminals across the world are trying to capitalize on peoples’ fears about COVID-19 to push counterfeit medicines or launch phishing campaigns by impersonating well-known pharma companies.
“Fake medicines are a real threat to the health and safety of patients around the world. With, hopefully, vaccines becoming available in the coming months, it is vital the industry gets to grip with online threats. We are excited to be working with the PSI in helping some of their members fight this danger.”
Click below to share this article
